D. D. E. Zimmerman

Elisabeth-TweeSteden Ziekenhuis

Papers

5

Total Citations

34

H-Index

3

About

D. D. E. Zimmerman is a leading colorectal surgeon and researcher whose work centers on optimizing surgical outcomes and quality of life for rectal cancer patients. His primary research focuses on comparing minimally invasive total mesorectal excision (TME) techniques—including laparoscopic, robot-assisted, and transanal approaches—to determine which yields the best functional results, oncological safety, and cost-effectiveness. Zimmerman’s major contributions include a landmark 2024 systematic review and meta-analysis (16 citations) that critically evaluated functional outcomes and quality of life across these surgical modalities, providing essential evidence for clinical decision-making. He also spearheaded the VANTAGE trial protocol (9 citations), a prospective multicenter observational cohort in the Netherlands designed to assess quality of life, functional outcomes, and cost-effectiveness in dedicated centers. His work extends to high-risk populations, such as overweight and obese patients, and includes developing predictive models for positive circumferential resection margins—a key factor in recurrence and survival. With several recent high-impact publications and leadership in the EUREKA collaborative, Zimmerman is shaping the future of evidence-based, patient-centered rectal cancer surgery.

Research Focus

Key Achievements

3
H-Index
5
Papers
34
Total Citations
7
Avg Citations/Paper
🏆 Most Cited Paper
Functional outcomes and quality of life following open versus laparoscopic versus robot-assisted versus transanal total mesorectal excision in rectal cancer patients: a systematic review and meta-analysis
16 citations · 2024
📈 Most Prolific Year: 2024 (3 Papers)
🤝 Key Collaborators: 83
🏛 Institutions: Elisabeth-TweeSteden Ziekenhuis

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago